Understanding Non-Hodgkin's Lymphomas

Jeannine M. Brant

Anne Robin Waldman

lymphoma, non-Hodgkin, radiotherapy, radioimmunotherapy, antineoplastic combined chemotherapy protocols
CJON 2003, 7(1), 93-96. DOI: 10.1188/03.CJON.93-96

The non-Hodgkin’s lymphomas (NHLs) have the second fastest rising incidence of cancer in the United States (Cure for Lymphoma Foundation, 1999), and since the 1970s, the number of new cases per year has nearly doubled (National Cancer Institute, 2000) as a result of improved detection and diagnostic methods, as well as an actual increase in the number of new cases. The incidence of NHL increases with age, and more than 50% of patients are older than 60 years of age at the time of diagnosis. In 2002, 53,900 new cases of NHL were diagnosed and 24,400 individuals died of the disease (Jemal, Thomas, Murray, & Thun, 2002).

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.